Neuropeptide Y (NPY) in neuroblastoma: Effect on growth and vascularization

Peptides

Volumn 28, Issue 2, 2007, Pages 405-412

  Kitlinska, Joanna ^a  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Angiogenesis; Neuroblastoma; Neuropeptide Y

Indexed keywords

NEUROPEPTIDE Y RECEPTOR; NEUROPEPTIDE Y2 RECEPTOR; NEUROPEPTIDE Y5 RECEPTOR; TUMOR MARKER;

ANGIOGENESIS; AUTOCRINE EFFECT; CANCER GROWTH; CANCER REGRESSION; CANCER STAGING; CELL PROLIFERATION; GENE EXPRESSION; GENE TARGETING; HORMONE BLOOD LEVEL; HUMAN; NEUROBLASTOMA; NEUROBLASTOMA CELL; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SYSTEMATIC REVIEW; TUMOR VASCULARIZATION;

CELL DIVISION; HUMANS; NEOVASCULARIZATION, PATHOLOGIC; NEUROBLASTOMA; NEUROPEPTIDE Y;

EID: 33846640185     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2006.08.038     Document Type: Review

References (69)

1. Allen J.M., Martin J.B., and Heinrich G. Neuropeptide Y gene expression in PC12 cells and its regulation by nerve growth factor: a model for developmental regulation. Brain Res 427 (1987) 39-43
2. Barnea A., and Roberts J. Induction of functional and morphological expression of neuropeptide Y (NPY) in cortical cultures by brain-derived neurotrophic factor (BDNF): evidence for a requirement for extracellular-regulated kinase (ERK)-dependent and ERK-independent mechanisms. Brain Res 919 (2001) 57-69
3. Barnea A., Roberts J., and Croll S.D. Continuous exposure to brain-derived neurotrophic factor is required for persistent activation of TrkB receptor, the ERK signaling pathway, and the induction of neuropeptide Y production in cortical cultures. Brain Res 1020 (2004) 106-117
4. Bayas A., Hummel V., Kallmann B.A., Karch C., Toyka K.V., and Rieckmann P. Human cerebral endothelial cells are a potential source for bioactive BDNF. Cytokine 19 (2002) 55-58
5. Beltinger C., and Debatin K.M. Murine models for experimental therapy of pediatric solid tumors with poor prognosis. Int J Cancer 92 (2001) 313-318
6. Bergers G., and Hanahan D. Combining antiangiogenic agents with metronomic chemotherapy enhances efficacy against late-stage pancreatic islet carcinomas in mice. Cold Spring Harb Symp Quant Biol 67 (2002) 293-300
7. Biedler J.L., Helson L., and Spengler B.A. Morphology and growth, tumorigenicity, and cytogenetics of human neuroblastoma cells in continuous culture. Cancer Res 33 (1973) 2643-2652
8. Biedler J.L., Roffler-Tarlov S., Schachner M., and Freedman L.S. Multiple neurotransmitter synthesis by human neuroblastoma cell lines and clones. Cancer Res 38 (1978) 3751-3757
9. Bjellerup P., Theodorsson E., Jornvall H., and Kogner P. Limited neuropeptide Y precursor processing in unfavourable metastatic neuroblastoma tumours. Br J Cancer 83 (2000) 171-176
10. Brodeur G.M. Neuroblastoma: biological insights into a clinical enigma. Nat Rev Cancer 3 (2003) 203-216
11. Brodeur G.M., Nakagawara A., Yamashiro D.J., Ikegaki N., Liu X.G., Azar C.G., et al. Expression of TrkA, TrkB and TrkC in human neuroblastomas. J Neurooncol 31 (1997) 49-55
12. Browder T., Butterfield C.E., Kraling B.M., Shi B., Marshall B., O'Reilly M.S., et al. Antiangiogenic scheduling of chemotherapy improves efficacy against experimental drug-resistant cancer. Cancer Res 60 (2000) 1878-1886
13. Carnahan J., and Nawa H. Regulation of neuropeptide expression in the brain by neurotrophins, Potential role in vivo. Mol Neurobiol 10 (1995) 135-149
14. Chlenski A., Liu S., and Cohn S.L. The regulation of angiogenesis in neuroblastoma. Cancer Lett 197 (2003) 47-52
15. Cohen P.S., Cooper M.J., Helman L.J., Thiele C.J., Seeger R.C., and Israel M.A. Neuropeptide Y expression in the developing adrenal gland and in childhood neuroblastoma tumors. Cancer Res 50 (1990) 6055-6061
16. Donovan M.J., Lin M.I., Wiegn P., Ringstedt T., Kraemer R., Hahn R., et al. Brain derived neurotrophic factor is an endothelial cell survival factor required for intramyocardial vessel stabilization. Development 127 (2000) 4531-4540
17. Dotsch J., Christiansen H., Hanze J., Lampert F., and Rascher W. Plasma neuropeptide Y of children with neuroblastoma in relation to stage, age and prognosis, and tissue neuropeptide Y. Regul Pept 75-76 (1998) 185-190
18. Eggert A., Grotzer M.A., Ikegaki N., Liu X.G., Evans A.E., and Brodeur G.M. Expression of the neurotrophin receptor TrkA down-regulates expression and function of angiogenic stimulators in SH-SY5Y neuroblastoma cells. Cancer Res 62 (2002) 1802-1808
19. Eggert A., Ikegaki N., Kwiatkowski J., Zhao H., Brodeur G.M., and Himelstein B.P. High-level expression of angiogenic factors is associated with advanced tumor stage in human neuroblastomas. Clin Cancer Res 6 (2000) 1900-1908
20. Ekstrand A.J., Cao R., Bjorndahl M., Nystrom S., Jonsson-Rylander A.C., Hassani H., et al. Deletion of neuropeptide Y (NPY) 2 receptor in mice results in blockage of NPY-induced angiogenesis and delayed wound healing. Proc Natl Acad Sci USA 100 (2003) 6033-6038
21. Erdreich-Epstein A., Shimada H., Groshen S., Liu M., Metelitsa L.S., Kim K.S., et al. Integrins alpha(v)beta3 and alpha(v)beta5 are expressed by endothelium of high-risk neuroblastoma and their inhibition is associated with increased endogenous ceramide. Cancer Res 60 (2000) 712-721
22. Ghersi G., Chen W., Lee E.W., and Zukowska Z. Critical role of dipeptidyl peptidase IV in neuropeptide Y-mediated endothelial cell migration in response to wounding. Peptides 22 (2001) 453-458
23. Hayashi Y., Ohi R., Sone M., Takahashi K., Mouri T., Watanabe T., et al. Significance of plasma neuropeptide Y (NPY) in diagnosis and prognosis of neuroblastoma. Prog Clin Biol Res 366 (1991) 359-365
24. Hofliger M.M., Castejon G.L., Kiess W., and Beck Sickinger A.G. Novel cell line selectively expressing neuropeptide Y-Y2 receptors. J Recept Signal Transduct Res 23 (2003) 351-360
25. Kim H., Li Q., Hempstead B.L., and Madri J.A. Paracrine and autocrine functions of brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF) in brain-derived endothelial cells. J Biol Chem 279 (2004) 33538-33546
26. Kitlinska J., Abe K., Kuo L., Pons J., Yu M., Li L., et al. Differential effects of neuropeptide Y on the growth and vascularization of neural crest-derived tumors. Cancer Res 65 (2005) 1719-1728
27. Kitlinska J., Kuo L., Tilan J., Abe K., Everhart L., Sun C., et al. Neuropeptide Y-a novel growth factor for neuroblastoma (2006), Advances in Neuroblastoma Research, Los Angeles, CA p. 73
28. Klement G., Baruchel S., Rak J., Man S., Clark K., Hicklin D.J., et al. Continuous low-dose therapy with vinblastine and VEGF receptor-2 antibody induces sustained tumor regression without overt toxicity. J Clin Invest 105 (2000) R15-R24
29. Kogner P., Bjork O., and Theodorsson E. Neuropeptide Y in neuroblastoma: increased concentration in metastasis, release during surgery, and characterization of plasma and tumor extracts. Med Pediatr Oncol 21 (1993) 317-322
30. Kogner P., Bjork O., and Theodorsson E. Plasma neuropeptide Y in healthy children: influence of age, anaesthesia and the establishment of an age-adjusted reference interval. Acta Paediatr 83 (1994) 423-427
31. Korner M., Waser B., and Reubi J.C. High expression of neuropeptide y receptors in tumors of the human adrenal gland and extra-adrenal paraganglia. Clin Cancer Res 10 (2004) 8426-8433
32. Koulu M., Movafagh S., Tuohimaa J., Jaakkola U., Kallio J., Pesonen U., et al. Neuropeptide Y and Y2-receptor are involved in development of diabetic retinopathy and retinal neovascularization. Ann Med 36 (2004) 232-240
33. Kraemer R., and Hempstead B.L. Neurotrophins: novel mediators of angiogenesis. Front Biosci 8 (2003) s1181-s1186
34. Lee E.W., Grant D.S., Movafagh S., and Zukowska Z. Impaired angiogenesis in neuropeptide Y (NPY)-Y2 receptor knockout mice. Peptides 24 (2003) 99-106
35. Lee E.W., Michalkiewicz M., Kitlinska J., Kalezic I., Switalska H., Yoo P., et al. Neuropeptide Y induces ischemic angiogenesis and restores function of ischemic skeletal muscles. J Clin Invest 111 (2003) 1853-1862
36. Li B.S., Kramer P.R., Zhao W., Ma W., Stenger D.A., and Zhang L. Molecular cloning, expression, and characterization of rat homolog of human AP-2alpha that stimulates neuropeptide Y transcription activity in response to nerve growth factor. Mol Endocrinol 14 (2000) 837-847
37. Magni P., Maggi R., Pimpinelli F., and Motta M. Cholinergic muscarinic mechanisms regulate neuropeptide Y gene expression via protein kinase C in human neuroblastoma cells. Brain Res 798 (1998) 75-82
38. Mannon P.J., and Kaiser L.M. Retinoic acid is a negative regulator of the neuropeptide Y/peptide YY Y1 receptor gene in SK-N-MC cells. J Neurochem 68 (1997) 20-25
39. Maris J.M. The biologic basis for neuroblastoma heterogeneity and risk stratification. Curr Opin Pediatr 17 (2005) 7-13
40. Maris J.M., and Matthay K.K. Molecular biology of neuroblastoma. J Clin Oncol 17 (1999) 2264-2279
41. Matsumoto K., Wada R.K., Yamashiro J.M., Kaplan D.R., and Thiele C.J. Expression of brain-derived neurotrophic factor and p145TrkB affects survival, differentiation, and invasiveness of human neuroblastoma cells. Cancer Res 55 (1995) 1798-1806
42. McConville C.M., and Forsyth J. Neuroblastoma-a developmental perspective. Cancer Lett 197 (2003) 3-9
43. Meitar D., Crawford S.E., Rademaker A.W., and Cohn S.L. Tumor angiogenesis correlates with metastatic disease, N-myc amplification, and poor outcome in human neuroblastoma. J Clin Oncol 14 (1996) 405-414
44. Minth-Worby C.A. Transcriptional regulation of the human neuropeptide Y gene by nerve growth factor. J Biol Chem 269 (1994) 15460-15468
45. Nakagawara A. Molecular basis of spontaneous regression of neuroblastoma: role of neurotrophic signals and genetic abnormalities. Hum Cell 11 (1998) 115-124
46. Nakagawara A. The NGF story and neuroblastoma. Med Pediatr Oncol 31 (1998) 113-115
47. Nakagawara A. Trk receptor tyrosine kinases: a bridge between cancer and neural development. Cancer Lett 169 (2001) 107-114
48. Nakagawara A., and Brodeur G.M. Role of neurotrophins and their receptors in human neuroblastomas: a primary culture study. Eur J Cancer 33 (1997) 2050-2053
49. Nakamura K., Martin K.C., Jackson J.K., Beppu K., Woo C.W., and Thiele C.J. Brain-derived neurotrophic factor activation of TrkB induces vascular endothelial growth factor expression via hypoxia-inducible factor-1alpha in neuroblastoma cells. Cancer Res 66 (2006) 4249-4255
50. O'Hare M.M., and Schwartz T.W. Expression and precursor processing of neuropeptide Y in human and murine neuroblastoma and pheochromocytoma cell lines. Cancer Res 49 (1989) 7015-7019
51. O'Hare M.M., and Schwartz T.W. Expression and precursor processing of neuropeptide Y in human pheochromocytoma and neuroblastoma tumors. Cancer Res 49 (1989) 7010-7014
52. Pons J., Kitlinska J., Ji H., Lee E.W., and Zukowska Z. Mitogenic actions of neuropeptide Y in vascular smooth muscle cells: synergetic interactions with the beta-adrenergic system. Can J Physiol Pharmacol 81 (2003) 177-185
53. Ribatti D., and Ponzoni M. Antiangiogenic strategies in neuroblastoma. Cancer Treat Rev 31 (2005) 27-34
54. Schramm A., Schulte J.H., Astrahantseff K., Apostolov O., Limpt V., Sieverts H., et al. Biological effects of TrkA and TrkB receptor signaling in neuroblastoma. Cancer Lett 228 (2005) 143-153
55. Schulte J.H., Schramm A., Klein-Hitpass L., Klenk M., Wessels H., Hauffa B.P., et al. Microarray analysis reveals differential gene expression patterns and regulation of single target genes contributing to the opposing phenotype of TrkA- and TrkB-expressing neuroblastomas. Oncogene 24 (2005) 165-177
56. Schwab M. Human neuroblastoma: from basic science to clinical debut of cellular oncogenes. Naturwissenschaften 86 (1999) 71-78
57. Schwab M. MYCN in neuronal tumours. Cancer Lett 204 (2004) 179-187
58. Shastry P., Basu A., and Rajadhyaksha M.S. Neuroblastoma cell lines-a versatile in vitro model in neurobiology. Int J Neurosci 108 (2001) 109-126
59. Sheriff S, A FQ, W TC, Kasckow JW, Balasubramaniam A. Predominant role by CaM kinase in NPY Y(1) receptor signaling: involvement of CREB [corrected]. Peptides 2002;23:87-96.
60. Sheriff S., Dayal R., Kasckow J., Regmi A., Chance W., Fischer J., et al. NPY upregulates genes containing cyclic AMP response element in human neuroblastoma cell lines bearing Y1 and Y2 receptors: involvement of CREB. Regul Pept 75-76 (1998) 309-318
61. Shusterman S., and Maris J.M. Prospects for therapeutic inhibition of neuroblastoma angiogenesis. Cancer Lett 228 (2005) 171-179
62. Srinivasan B., Roque C.H., Hempstead B.L., Al-Ubaidi M.R., and Roque R.S. Microglia-derived pronerve growth factor promotes photoreceptor cell death via p75 neurotrophin receptor. J Biol Chem 279 (2004) 41839-41845
63. Tacconelli A., Farina A.R., Cappabianca L., Desantis G., Tessitore A., Vetuschi A., et al. TrkA alternative splicing: a regulated tumor-promoting switch in human neuroblastoma. Cancer Cell 6 (2004) 347-360
64. Whang-Peng J., Triche T.J., Knutsen T., Miser J., Kao-Shan S., Tsai S., et al. Cytogenetic characterization of selected small round cell tumors of childhood. Cancer Genet Cytogenet 21 (1986) 185-208
65. Wirth M.J., Patz S., and Wahle P. Transcellular induction of neuropeptide Y expression by NT4 and BDNF. Proc Natl Acad Sci USA 102 (2005) 3064-3069
66. Yoon H.Z., Yan Y., Geng Y., and Higgins R.D. Neuropeptide Y expression in a mouse model of oxygen-induced retinopathy. Clin Experiment Ophthalmol 30 (2002) 424-429
67. Zukowska-Grojec Z., Karwatowska-Prokopczuk E., Fisher T.A., and Ji H. Mechanisms of vascular growth-promoting effects of neuropeptide Y: role of its inducible receptors. Regul Pept 75-76 (1998) 231-238
68. Zukowska-Grojec Z., Karwatowska-Prokopczuk E., Rose W., Rone J., Movafagh S., Ji H., et al. Neuropeptide Y: a novel angiogenic factor from the sympathetic nerves and endothelium. Circ Res 83 (1998) 187-195
69. Zukowska-Grojec Z., Pruszczyk P., Colton C., Yao J., Shen G.H., Myers A.K., et al. Mitogenic effect of neuropeptide Y in rat vascular smooth muscle cells. Peptides 14 (1993) 263-268